Bacterial Antigen Ingredients TRIZ Cases

Multivalent immunogenic compositions containing capsular polysaccharides from serotype 24F and other pneumococcal strains.

Poly(diaminosulfide) particles encapsulate leptospiral antigens to stimulate durable immune responses.

Heterologous acyl transferases shorten lipid A chains on modified Bordetella lipopolysaccharide, reducing endotoxicity while preserving vaccine immunogenicity.

A histidine-succinic acid buffer system and pH shift optimize polysaccharide-protein conjugate adsorption onto aluminium adjuvants.

A non-denatured toxoid associates with a cellular membrane nanoparticle to preserve antigenic structure and prevent residual toxicity.

Multi-component glycoconjugates expand protection against emerging pneumococcal serotypes, resolving coverage gaps in existing vaccines.

Isolated metal-regulated polypeptides disrupt bacterial iron acquisition to reduce colonization and treat liver abscesses in cattle.

Neurotoxin-associated proteins protect tetanus vaccine from gastric acidity and proteases, enabling painless oral delivery without needle injections.

Segmented formulation prevents antigen incompatibility while lyophilization ensures durability, yielding neutralizing antibodies for 200 days.

Segmented influenza proteins expressed in a modified Bordetella vector provide broad protection while eliminating genetic reversion risks.

Undirected mutated mRNA vaccines incorporate diverse mutant sequences to overcome slow development times and provide polyvalent protection.

A lipopolysaccharide compound modulates the TLR4 signaling pathway to activate poultry immunity against coccidiosis.

Alum adjuvant mediates co-administration of dengue and MMR vaccines, resolving immune response incompatibilities while simplifying vaccination schedules.

Removing PEG coatings from PLGA nanoparticles eliminates adverse conditions while maintaining controlled drug release.

Epitope-based antibodies bind toxins A and B to neutralize their activity, reducing infection severity without antibiotic resistance.

Combining Mycoplasma hyopneumoniae, PCV2, and PRRSV antigens in one formulation eliminates efficacy interference between separate injections.

A detoxified pertussis vaccine combines purified antigens with enzyme-treated lipopolysaccharide to preserve protective immune response strength.

Conjugating Streptococcus pneumoniae serotypes 23A and 23B to carrier proteins overcomes poor infant immune response to unconjugated polysaccharides.

Pollen spores deliver antigens through porous microspheres, protecting them from stomach acid to enable safe oral immunization.

Segmented VLP scaffolds combine with antigens to boost immunogenicity while maintaining subunit vaccine safety.

A non-live Lawsonia intracellularis vaccine administered systemically to pigs.

Attenuated Salmonella vector expressing fliC and CD154 reduces morbidity while enhancing cross-protection.

BAdv85C5 adenovirus vaccine overcomes partial BCG protection by using autophagy-inducing peptide C5 to enhance antigen presentation and reduce lung burden.

Defined evpB gene mutation creates vaccine strain eliminating antibiotic resistance traits while maintaining efficacy.

Periodate oxidation activates capsular polysaccharides to covalently bind carrier proteins like CRM197.

Extramuscular Botulinum toxin injection minimizes muscle weakness by targeting fascial planes instead of intra-muscular sites.

Composite vaccine with iron-regulated polypeptides provides broad-spectrum protection against diverse Bacillus species including B. anthracis.

HMGN polypeptides bind dendritic cells to activate antigen-specific immune responses and shift the Th-1/Th-2 balance toward a protective Th-1 state.

Liposome-embedded MPLA adjuvant combined with mutant rPA protein reduces reactogenicity while maintaining protective immunity against anthrax.

Conjugating Streptococcus pneumoniae polysaccharides to carrier proteins in DMSO resolves poor immunogenicity in infants by enabling stronger immune responses.

Placing Carbopol and DDA adjuvants in the aqueous phase of water-in-oil emulsions enhances immunogenicity while preventing adverse reactivity.

Specific E. ewingii polypeptides resolve uncultivable pathogen diagnosis by enabling accurate antibody differentiation from other ehrlichiosis agents.

Modified mRNA vaccine encodes bacterial proteins to trigger targeted immune responses against tumors.

Extracellular matrix digesting enzymes break down tissue barriers to enhance botulinum toxin diffusion.

Ketone or oxime modified saponin adjuvants resolve QS-21 toxicity and instability by replacing natural extraction with synthetic sp2 hybridized structures.

Foam compositions deliver anti-cancer agents directly to body cavities using propellant-driven reservoirs.

Cold-adapted modified live canine parainfluenza virus provides single-dose immunity against upper respiratory diseases without parenteral injection.

Replacing phosphate buffers with a dual carboxylate and bicarbonate system enables stable, low-volume oral rotavirus vaccines for infants.

A Rev-dependent lentiviral vector delivers therapeutic genes to infected cells, inducing apoptosis and eliminating viral reservoirs.

Linking Pseudomonas flagellin to Klebsiella polysaccharides overcomes poor immunogenicity of pure antigens.

A multivalent glycoconjugate vaccine formulation expresses multiple epitopes on a single carrier protein to maintain immunogenicity.

Heat-killed Caulobacter crescentus adjuvant overcomes inadequate immune modulation by inducing robust T cell proliferation and antibody production.

Replacing oil adjuvants with an acrylic acid polymer eliminates injection site reactions while maintaining effective immunity against Mycoplasma hyopneumoniae.

Conjugating a conserved CSP peptide to Q beta VLPs overcomes moderate protection and limited durability of existing malaria vaccines.

Cultivating Lactobacillus fermentum GKF3 under optimized conditions boosts neurotransmitter concentrations to treat psychataxia symptoms.

Specialized transducing phage deletes the esx-3 region from Mycobacterium tuberculosis to create viable attenuated strains.

Aquifex aeolicus CD4+ helper epitopes boost antibody production to resolve weak immune responses from peptide vaccines lacking MHC-II binding.

Nanolipoprotein particles co-localize Francisella polysaccharide and protein antigens with an adjuvant to stimulate immune responses.